STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

QGEN Form 144 Discloses 68,577 Shares Sold Recently; 31,423 Proposed Sale

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

QGEN Form 144 summary: This filing notifies a proposed sale under Rule 144 of 31,423 common shares by an insider brokered through Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $1,546,256.70 and an approximate sale date of 08/15/2025. The shares were acquired as performance shares on 02/28/2025. The filing also reports sales by the same person during the prior three months totaling 68,577 common shares for gross proceeds of $3,336,720.01 across trades on 08/13–08/14/2025. The filer certifies no undisclosed material adverse information.

Positive

  • Disclosure compliance: The filer provides required Rule 144 details including broker, class, acquisition date and nature of acquisition.
  • Acquisition clarity: Shares to be sold were acquired as performance shares on 02/28/2025, explicitly stated.

Negative

  • Insider selling activity: The person sold 68,577 shares in the prior three months, which may be perceived negatively by some investors.
  • Significant proposed sale: The planned sale of 31,423 shares equals an aggregate market value of $1,546,256.70.

Insights

TL;DR Insider intends to sell 31,423 performance shares worth $1.55M; recent insider sales totaled 68,577 shares.

The filing documents a planned Rule 144 sale of 31,423 common shares obtained as performance compensation on 02/28/2025. The timing and size are explicit, with an indicated broker and exchange. Recent dispositions totaling 68,577 shares generated reported gross proceeds of $3,336,720.01, which quantifies recent liquidity events by the holder. These facts are material for monitoring insider selling trends but provide no operational or financial performance details about the issuer.

TL;DR Multiple recent insider sales and a planned Rule 144 disposition are disclosed; filings comply with certification language.

The notice shows compliance with Rule 144 procedures: identification of broker, class, acquisition date, nature of acquisition (performance shares) and signature representation about material nonpublic information. The schedule of recent sales is detailed by date, share count and gross proceeds. From a governance perspective, disclosure is complete on the transactions reported, but the document contains no information on any trading plan adoption or restrictions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does QGEN's Form 144 notify?

It notifies a proposed Rule 144 sale of 31,423 common shares via Morgan Stanley Smith Barney on the NYSE with an approximate sale date of 08/15/2025.

How were the shares being sold by the QGEN insider acquired?

The shares were acquired as performance shares on 02/28/2025 and the filing lists the acquisition date and nature explicitly.

How many shares did the insider sell in the past three months?

The filing reports 68,577 shares sold on 08/13–08/14/2025 for combined gross proceeds of $3,336,720.01.

What is the dollar value of the proposed sale in the Form 144?

The aggregate market value is $1,546,256.70 for the 31,423 common shares to be sold.

Which broker and exchange are involved in the proposed sale?

Morgan Stanley Smith Barney LLC is the named broker and the sale is listed for the NYSE.
Qiagen

NYSE:QGEN

QGEN Rankings

QGEN Latest News

QGEN Latest SEC Filings

QGEN Stock Data

10.43B
215.76M
1.61%
88.24%
3.1%
Diagnostics & Research
Healthcare
Link
Netherlands
Venlo